Connor, Clark & Lunn Investment Management (CC&L)’s Fulgent Genetics FLGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.07M | Buy |
305,180
+55,521
| +22% | +$1.1M | 0.02% | 524 |
|
|
2025
Q1 | $4.22M | Buy |
249,659
+123,702
| +98% | +$2.09M | 0.02% | 541 |
|
|
2024
Q4 | $2.33M | Buy |
125,957
+112,011
| +803% | +$2.07M | 0.01% | 682 |
|
|
2024
Q3 | $303K | Buy |
+13,946
| New | +$303K | ﹤0.01% | 1236 |
|
|
2022
Q1 | – | Sell |
-6,649
| Closed | -$669K | – | 1089 |
|
|
2021
Q4 | $669K | Buy |
+6,649
| New | +$669K | ﹤0.01% | 747 |
|